ArticleTechnology in cancer research & treatment

Letter to the Editor: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer.

Hinpetch Daungsupawong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.